Alan Butcher

J. Alan Butcher

Senior Vice President, Business Development and Strategic Portfolio Management

Alan Butcher joined Purdue in April 2015. He is a highly experienced pharmaceutical executive who has completed multiple high-value transactions throughout his career. Mr. Butcher has been responsible for developing business strategy; product candidate and delivery technology development; P&L management; and managing the valuation, negotiation, and execution of licensing deals and company acquisitions.

Mr. Butcher previously was Vice President of Business Development at Shire Pharmaceuticals; Vice President and General Manager of Implant Drug Delivery and Vice President of Business and Corporate Development for Endo Pharmaceuticals; Director of Worldwide Business Development Transactions at GlaxoSmithKline; and several positions at Bristol-Myers Squibb in business development and scientific research.

Mr. Butcher holds a Bachelor’s of Science in Clinical Microbiology and a Master’s of Arts in Biology with a concentration in Molecular Biology and Genetics from West Chester University of Pennsylvania. He also is a graduate of Cornell University’s Johnson Graduate School of Management.

Download Bio

Leadership page

The prescription and illicit opioid abuse crisis is a multifaceted public health challenge, and as a manufacturer of prescription opioids, we have a responsibility to join the fight. At Purdue we are committed to lead our industry in helping address our nation's prescription and illicit opioid abuse crisis.

There is more to come – as we continue to work with partners and experts to deliver solutions. Below you will find additional information about our efforts.

Read our open letter about the opioid crisis.